Internet Archive Scholar

Antiglucocorticoid and related treatments for psychosis [entry]

Belinda Garner, Lisa Phillips, Sarah Bendall, Ruth Parslow, Sarah E Hetrick, Belinda Garner
2008 Cochrane Database of Systematic Reviews   unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.3 MB)
https://web.archive.org/web/20200310083146/https://minerva-access.unimelb.edu.au/bitstream/handle/11343/59271/Garner%20antiglucocorticoids.pdf;jsessionid=84DF8DB6BEB738A9BC43E80D04E3A778?sequence=1

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Analysis 1.1. Comparison 1 Any antiglucocorticoid versus placebo as sole treatment (data only for mifepristone), Outcome 1 Mental state: 1. General -average endpoint score (BPRS total scores, higher score = poor). . . . . . . . Analysis 1.2. Comparison 1 Any antiglucocorticoid versus placebo as sole treatment (data only for mifepristone), Outcome 2 Mental state: 2. Specific -depression -average endpoint score (HAMD total, higher score = poor). . . . . Analysis 1.3. Comparison 1 Any
more » ... icoid versus placebo as sole treatment (data only for mifepristone), Outcome 3 Global state: 1. General -no clinically significant improvement (< 30% reduction BPRS). . . . . . . . Analysis 1.4. Comparison 1 Any antiglucocorticoid versus placebo as sole treatment (data only for mifepristone), Outcome 4 Global state: 2a. Specific -positive symptoms -no clinically significant improvement (< 50% reduction BPRS,
doi:10.1002/14651858.cd006995 fatcat:ghdnussjxzbchpoxshwbf6do5e
Citation

Belinda Garner, Lisa Phillips, Sarah Bendall, Ruth Parslow, Sarah E Hetrick, Belinda Garner. "Antiglucocorticoid and related treatments for psychosis." Cochrane Database of Systematic Reviews (2008)